Cedar Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-12	Closed	-$5.63K	–	305
2024 Q2	$5.63K	Hold	12	–	–	﹤0.01%	257
2024 Q1	$5.02K	Buy	+12	New	+$5.07K	﹤0.01%	283
2022 Q3	–	Sell	-319	Closed	-$90K	–	348
2022 Q2	$90K	Sell	319 -5	-2%	-$1.34K	0.04%	137
2022 Q1	$85K	Sell	324 -45	-12%	-$10.7K	0.03%	147
2021 Q4	$81K	Sell	369 -156	-30%	-$30.3K	0.03%	157
2021 Q3	$95K	Buy	525 +81	+18%	+$15.8K	0.04%	133
2021 Q2	$90K	Buy	+444	New	+$92.9K	0.04%	143
2018 Q3	–	Sell	-28	Closed	-$5K	–	230
2018 Q2	$5K	Buy	+28	New	+$4.34K	﹤0.01%	169
2017 Q4	–	Sell	-15	Closed	-$2K	–	148
2017 Q3	$2K	Hold	15	–	–	﹤0.01%	126
2017 Q2	$2K	Hold	15	–	–	﹤0.01%	128
2017 Q1	$2K	Hold	15	–	–	﹤0.01%	128
2016 Q4	$1K	Hold	15	–	–	﹤0.01%	129
2016 Q3	$1K	Hold	15	–	–	﹤0.01%	119
2016 Q2	$1K	Buy	+15	New	+$1.3K	﹤0.01%	125